Is There any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?

Prostate

Volumn 75, Issue 3, 2015, Pages 225-232

  Zhao, Tao ^a   Liao, Banghua ^a   Yao, Jin ^a   Liu, Jiyan ^a   Huang, Rui ^a   Shen, Pengfei ^a   Peng, Zhufeng ^a   Gui, Haojun ^a   Chen, Xueqin ^a   Zhang, Peng ^a   Zhu, Yuchun ^a   Li, Xiang ^a   Wei, Qiang ^a   Zhou, Qiao ^a   Zeng, Hao ^a   Chen, Ni ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIANDROGEN; HEMOGLOBIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CONTROLLED STUDY; DISEASE COURSE; FINE NEEDLE ASPIRATION BIOPSY; GLEASON SCORE; HUMAN; IMAGE GUIDED BIOPSY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE INTRADUCTAL CARCINOMA; TESTOSTERONE BLOOD LEVEL; TUMOR DIFFERENTIATION; ULTRASONIC GUIDED TRANSPERINEAL NEEDLE BIOPSY; ADENOCARCINOMA; CANCER GRADING; MIDDLE AGED; MULTIPLE CANCER; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SECONDARY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, DUCTAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 84920733832     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22906     Document Type: Article

References (18)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Chen XQ, Huang Y, Li X, Zhang P, Huang R, Xia J, Chen N, Wei Q, Zhu YC, Yang YR, Zeng H. Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: A retrospective clinical experience from a Chinese medical centre. Asian J Androl 2010; 12: 718-727.
3. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer 1985; 56: 1566-1573.
4. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 1996; 20: 802-814.
5. Wilcox G, Soh S, Chakraborty S, Wheeler TM. Patterns of highgrade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol 1998; 29: 1119-1123.
6. Rubin MA, de La Taille A, Bagiella E, Olsson CA, O'Toole KM. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: Incidence and clinical implications. Am J Surg Pathol 1998; 22: 840-848.
7. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: Significance for cancer progression. Prostate 2000; 43: 11-19.
8. Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P. Morphologic characterization of preoperatively treated prostate cancer: Toward a post-therapy histologic classification. Eur Urol 2010; 57: 1030-1038.
9. Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: Emphasis on radical prostatectomy findings. J Urol 2010; 184: 1328-1333.
10. Van der Kwast T, Al Daoud N, Collette L, Sykes J, Thoms J, Milosevic M, Bristow RG, Van Tienhoven G, Warde P, Mirimanoff RO, Bolla M. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur J Cancer 2012; 48: 1318-1325.
11. Kimura K, Tsuzuki T, Kato M, Saito AM, Sassa N, Ishida R, Hirabayashi H, Yoshino Y, Hattori R, Gotoh M. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate 2014; 74: 680-687.
12. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th edition. Oxford, UK: Blackwell publishing Ltd.; 2009.
13. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol 2006; 19: 1528-1535.
14. Cohen RJ, Chan WC, Edgar SG, Robinson E, Dodd N, Hoscek S, Mundy IP. Prediction of pathological stage and clinical outcome in prostate cancer: An improved pre-operative model incorporating biopsy-determined intraductal carcinoma. Br J Urol 1998; 81: 413-418.
15. Robinson B, Magi-Galluzzi C, Zhou M. Intraductal carcinoma of the prostate. Arch Pathol Lab Med 2012; 136 (4): 418-425.
16. Pickup M, Van der Kwast TH. My approach to intraductal lesions of the prostate gland. J Clin Pathol 2007; 60: 856-865.
17. O'Brien BA, Cohen RJ, Wheeler TM, Moorin RE. A post-radicalprostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis. BJU Int 2011; 107: 389-395.
18. Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, van der Kwast TH. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. Eur J Cancer 2014; 50: 1610-1616.